Could a virtual game help pandemic studies?

USA - Online game worlds might prove useful for the study of a spread of human infectious diseases, according to scientists Eric Lofgren and Nina Fefferman, of Rutgers University (Piscataway, NJ, USA) and Tufts University (Boston, MA, USA).

Hakkar, the primary source of infection in World of Warcraft
Hakkar, the primary source of infection in World of Warcraft

In the September issue of The Lancet Infectious Diseases they describe how a programming error in a popular online role-playing game, World of Warcraft, caused a full-blown epidemic of a virulent, highly contagious disease. Although computer models of infectious diseases are of increasing importance, a limitation of these models is that they cannot predict the behaviour of individuals. The scientists realised that appropriate exploitation of online games might alleviate this constraint, since players’ economic and social behaviour often mimics their real-world behaviour.

The outbreak began when Blizzard Entertainment released an update in September 2005, allowing higher level players to access a new area of the game. Players experienced combat with a powerful creature called Hakkar, who occasionally infected players with ‘Corrupted Blood’. To the powerful players Corrupted Blood was no more of a hindrance than a cold, but a game-wide epidemic started after many characters teleported – a common feature of the game – back to urban areas before being killed or cured of the disease, where they infected more susceptible players.

Blizzard Entertainment’s quarantine strategy failed because of the highly contagious nature of the disease, the inability to seal off a section of the game world effectively, and player resistance to the notion. Fortunately, the game developers had one additional option not available to public-health officials: resetting the computers.

This is the first time a virtual virus has infected a virtual human being in a manner even remotely resembling an actual epidemiological event. Currently, epidemiologists face major constraints in studies of diseases dynamics because they are limited to observational and retrospective studies. Computer models allow for experimentation on virtual populations without such limitations, but they rely on mathematical rules to approximate human behaviour. By contrast, human-agent virtual simulation may bridge the gap between real world epidemiological studies and large-scale computer studies by including the variability and unexpected outcomes that arise as a result of the behaviour of individuals. Lofgren and Fefferman say: ‘We believe that, if the epidemic is designed and presented so as to seamlessly integrate with the rest of the persistent game world, in such a way as to be part of the user’s expected experience in the game, a reasonable analogue to real-world human reactions to disease might be observed and captured within a computer model...By using these games as an untapped experimental framework, we may be able to gain deeper insight into the incredible complexity of infectious disease epidemiology in social groups.’
Source: The Lancet
Details: Nina Fefferman.
Phone: +1 781 710-5025
Email: feferman@math.princeton.edu

31.08.2007

More on the subject:

Related articles

Photo

News • Immunology

“One and done”: promise for a universal influenza vaccine

New research reveals a promising approach to developing a universal influenza vaccine that confers lifetime immunity against an evolving virus considered most likely to trigger the next pandemic.

Photo

News • Improved infection protection

S. aureus: One step closer to a vaccine

Staphylococcus aureus is a leading cause of hospital-acquired bacterial infection, associated with over one million deaths worldwide each year. Now, researchers could be one step closer to a vaccine.

Photo

News • Focus on microproteins

Researchers find potential target for liver cancer vaccine

Microproteins hold great promise, according to new research: Since they are only expressed by liver tumor cells, the proteins could serve as a potential target for cancer vaccine development.

Related products

Subscribe to Newsletter